<DOC>
	<DOCNO>NCT01702792</DOCNO>
	<brief_summary>This non-randomized , open-label study patient newly diagnose glioblastoma determine ability generate human hybridoma lymph node drain autologous tumor vaccine injection demonstrate hybridomas secrete glioblastoma-specific antibody .</brief_summary>
	<brief_title>Derivation Tumor Specific Hybridomas</brief_title>
	<detailed_description>The intradermal vaccine inject 20cm anterior thigh . Vaccination do twice separate one week . The first vaccination perform approximately 2 week surgery . Approximately one week second vaccination one two vaccine-draining lymph node ( ) remove . The lymph node ( ) identify use SN technology . One two lymph node ( ) remove . Lymph node process recovery B cell formation hybridoma .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients confirm new diagnosis glioblastoma yield least 8x10 ( 7 ) tumor cell obtain time surgery Age &gt; 18 year KPS Score great equal 70 Adequate bone marrow evidence : Absolute lymphocyte count &gt; 1,000/uL Platelet count &gt; 50,000/uL Adequate renal function evidence serum creatinine &lt; 2.0 Patients must able read , understand provide inform consent participate trial . Patients childbearing potential must agree use effective form contraception study 90 day follow vaccination ( effective form contraception oral contraceptive double barrier method ) A patient may enrol trial follow criterion meet : Patients receive dexamethasone &gt; 8 mg/day week vaccination . Patients pregnant lactate Patients active second malignancy . Any medical condition , include mental illness substance abuse , deem Investigator likely interfere patient 's ability sign inform consent , cooperate participate study , interfere interpretation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Immunotherapy , cancer vaccine , glioblastoma , hybridoma</keyword>
</DOC>